Phase I study of epitope peptides with UFT/UZEL for unresectable colorectal cancer

Phase I study of epitope peptides with UFT/UZEL for unresectable colorectal cancer - Phase I study of epitope peptides with UFT/UZEL for unresectable colorectal cancer

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003728

Enrollment

Registered

2010-06-09

Start date

2007-01-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

unresectable colorectal cancer

Interventions

Vaccination using epitope peptide from RNF43 and TOMM34

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Performance status 0-2 HLA-A24 Good function of critical organs Written informed consents etc,

Exclusion criteria

Exclusion criteria: 1.Plegnant 2. Breastfeeding 3. Wish for pregnancy 4. Active infection 5. Steroid or immunosuppressive therapy 6. Multiple cancer 7. Doctors opinion

Design outcomes

Primary

Measure	Time frame
safety	—

Secondary

Measure	Time frame
immunological response efficacy	—

Countries

Japan

Contacts

Public ContactFumiaki Sugiura

Kinki University School of Medicine Department of Surgery

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026